Anti-inflammatory effects of Calophyllum inophyllum L. in RAW264.7 cells

Oncology Reports

Volumn 28, Issue 3, 2012, Pages 1096-1102

  Tsai, Shih Chang ^a   Liang, Yu Hsin ^a   Chiang, Jo Hua ^b   Liu, Fon Chang ^a   Lin, Wen Hsin ^c   Chang, Shu Jen ^a   Lin, Wei Yu ^c   Wu, Chieh Hsi ^a   Weng, Jing Ru ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c Kinmen Hospital   (Taiwan)

Author keywords

Anti inflammatory effect; Calophyllum inophyllum L.; MicroRNA; Traditional Chinese herbs

Indexed keywords

ANTIINFLAMMATORY AGENT; CALOPHYLLUM INOPHYLLUM EXTRACT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA; MICRORNA 146A; MICRORNA 155; MICRORNA 424; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALOPHYLLUM; CALOPHYLLUM INOPHYLLUM; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; IC 50; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIFLAVONOIDS; CALOPHYLLUM; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 2; GENE EXPRESSION; INHIBITORY CONCENTRATION 50; LIPOPOLYSACCHARIDES; MICE; MICRORNAS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OLEANOLIC ACID; PLANT EXTRACTS; PLANT LEAVES; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR RELA;

EID: 84865327990     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1873     Document Type: Article

References (46)

1. Guha M and Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001.
2. Kleinert H, Schwarz PM and Forstermann U: Regulation of the expression of inducible nitric oxide synthase. Biol Chem 384: 1343-1364, 2003.
3. Goldring CE, Reveneau S, Pinard D and Jeannin JF: Hyporesponsiveness to lipopolysaccharide alters the composition of NF-kappaB binding to the regulatory regions of inducible nitric oxide synthase gene. Eur J Immunol 28: 2960-2970, 1998.
4. Turini ME and DuBois RN: Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53: 35-57, 2002.
5. Williams JA and Shacter E: Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. J Biol Chem 272: 25693-25699, 1997.
6. Wang H, Gao X, Fukumoto S, Tademoto S, Sato K and Hirai K: Post-isolation inducible nitric oxide synthase gene expression due to collagenase buffer perfusion and characterization of the gene regulation in primary cultured murine hepatocytes. J Biochem 124: 892-899, 1998.
7. Baeuerle PA and Baltimore D: NF-kappa B: ten years after. Cell 87: 13-20, 1996.
8. Rothwarf DM and Karin M: The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999: RE1, 1999.
9. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Hobert O: Gene regulation by transcription factors and microRNAs. Science 319: 1785-1786, 2008.
11. Pedersen I and David M: MicroRNAs in the immune response. Cytokine 43: 391-394, 2008.
12. Rosa A, Ballarino M, Sorrentino A, et al: The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 104: 19849-19854, 2007.
13. Doggrell SA: Inflammation, the key to much pathology. Drug News Perspect 18: 531-539, 2005.
14. Moon TC, Kim JC, Song SE, et al: Saucerneol D, a naturally occurring sesquilignan, inhibits LPS-induced iNOS expression in RAW264.7 cells by blocking NF-kappaB and MAPK activation. Int Immunopharmacol 8: 1395-1400, 2008.
15. Vodovotz Y, Lucia MS, Flanders KC, et al: Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 184: 1425-1433, 1996.
16. Venkanna BK and Venkataramana Reddy C: Biodiesel production and optimization from Calophyllum inophyllum linn oil (honne oil) - a three stage method. Bioresour Technol 100: 5122-5125, 2009.
17. Kawazu K, Ohigashi H and Mitsui T: The piscicidal constituents of Calophyllum inophyllum Linn. Tetrahedron Lett 19: 2383-2385, 1968.
18. Govindachari TR, Viswanathan N, Pai BR, Rao R and Srinivasan M: Triterpenes of Calophyllum inophyllum Linn. Tetrahedron 23: 1901-1910, 1967.
19. Arora RB, Mathur CN and Seth SD: Calophyllolide, a complex coumarin anticoagulant from Calophyllum inophyllum Linn. J Pharm Pharmacol 14: 534-535, 1962.
20. Li YZ, Li ZL, Yin SL, et al: Triterpenoids from Calophyllum inophyllum and their growth inhibitory effects on human leukemia HL-60 cells. Fitoterapia 81: 586-589, 2010.
21. Dai HF, Zeng YB, Xiao Q, Han Z, Zhao YX and Mei WL: Caloxanthones O and P: two new prenylated xanthones from Calophyllum inophyllum. Molecules 15: 606-612, 2010.
22. Spino C, Dodier M and Sotheeswaran S: Anti-HIV coumarins from Calophyllum seed oil. Bioorg Med Chem Lett 8: 3475-3478, 1998.
23. De Clercq E: Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med Res Rev 20: 323-349, 2000.
24. Said T, Dutot M, Labbe A, Warnet JM and Rat P: Ocular burn: rinsing and healing with ionic marine solutions and vegetable oils. Ophthalmologica 223: 52-59, 2009.
25. Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC and Chung JG: MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J Pharmacol Exp Ther 334: 477-488, 2010.
26. Wu PP, Liu KC, Huang WW, et al: Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway. Oncol Rep 25: 551-557, 2011.
27. Lin MW, Tsao LT, Huang LJ, et al: Inhibition of lipopolysaccharide- stimulated NO production by crotafuran B in RAW 264.7 macrophages involves the blockade of NF-kappaB activation through the increase in IkappaBalpha synthesis. Toxicol Appl Pharmacol 210: 108-115, 2006.
28. Andrews NC and Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.
29. Tsai SC and Seto E: Regulation of histone deacetylase 2 by protein kinase CK2. J Biol Chem 277: 31826-31833, 2002.
30. Chiang JH, Yang JS, Ma CY, et al: Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways. Chem Res Toxicol 24: 20-29, 2011.
31. Lu CC, Yang JS, Huang AC, et al: Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Mol Nutr Food Res 54: 967-976, 2010.
32. Jeon YJ, Han SB, Ahn KS and Kim HM: Differential activation of murine macrophages by angelan and LPS. Immunopharmacology 49: 275-284, 2000.
33. Kuo CT, Chiang LL, Lee CN, et al: Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase C- and nuclear factor-κB-dependent mechanisms. J Biomed Sci 10: 136-145, 2003.
34. Denlinger LC, Fisette PL, Garis KA, et al: Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 271: 337-342, 1996.
35. Surh YJ, Chun KS, Cha HH, et al: Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480-481: 243-268, 2001.
36. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
37. Simeonidis S, Liang S, Chen G and Thanos D: Cloning and functional characterization of mouse IkappaBepsilon. Proc Natl Acad Sci USA 94: 14372-14377, 1997.
38. Gilroy DW, Lawrence T, Perretti M and Rossi AG: Inflammatory resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3: 401-416, 2004.
39. Ghosh S and Karin M: Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl): S81-S96, 2002.
40. Li Y, Vandenboom TG II, Wang Z, et al: miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res 70: 1486-1495, 2010.
41. Chan EK, Satoh M and Pauley KM: Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? Arthritis Rheum 60: 912-915, 2009.
42. Nahid MA, Pauley KM, Satoh M and Chan EK: miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 284: 34590-34599, 2009.
43. Li YZ, Li ZL, Hua HM, Li ZG and Liu MS: Studies on flavonoids from stems and leaves of Calophyllum inophyllum. Zhongguo Zhong Yao Za Zhi 32: 692-694, 2007.
44. Shin DH, Bae YC, Kim-Han JS, et al: Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic-ischemic brain damage via multiple mechanisms. J Neurochem 96: 561-572, 2006.
45. Pereira DA, Dalmarco JB, Wisniewski A Jr, Simionatto EL, Pizzolatti MG and Frode TS: Lotus corniculatus regulates the inflammation induced by bradykinin in a murine model of pleurisy. J Agric Food Chem 59: 2291-2298, 2011.
46. Sung HY, Kang SW, Kim JL, et al: Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes. Nutr Res 30: 831-839, 2010.